Day: June 11, 2026

O2 and Mavenir successfully trial technology to improve call clarity for people with hearing loss

O2 has successfully trialled new technology to provide clearer phone calls for customers with hearing loss The trial was carried out with Mavenir and created a personalised hearing profile for each participant, allowing the network to automatically optimise calls in real time Working seamlessly in the background, the technology helped overcome the everyday frustration of […]

Read More »

Information on the total number of voting rights and shares.

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 10, 2026, 11:00 pm CET / 5:00 pm ET – In accordance with article 15 of the Law of May 2, 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issuance of 55,232,558 new shares in connection with […]

Read More »

$110 Million in Aggregate Financings to Accelerate Genio’s U.S. Commercial Launch

$110 Million in Aggregate Financings to Accelerate Genio’s U.S. Commercial Launch Mont-Saint-Guibert, Belgium – June 10, 2026, 10:30 pm CET / 04:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), has completed a $95 million equity financing and […]

Read More »

Nyxoah Announces Closing of Underwritten Public Offering

REGULATED INFORMATION Nyxoah Announces Closing of Underwritten Public Offering Mont-Saint-Guibert, Belgium – June 10, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext Brussels/ Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA), today announced the closing of its previously announced underwritten […]

Read More »